Evaluating the Quality-of-Life Effect of Apical Spacing with Hyaluronic Acid Prior to Hypofractionated Prostate Radiation Therapy: A Secondary Analysis
Practical Radiation Oncology · 2024
DOI: 10.1016/j.prro.2023.11.010 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Practical Radiation Oncology, 2024. Verfasst von Martin T King und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston, Massachusetts. Electronic address: martin_king…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Quality of Life, Prostatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PURPOSE: Recently, a randomized trial demonstrated that a hyaluronic acid (HA) spacer placed before prostate hypofractionated intensity modulated radiation therapy improved rectal dosimetry and reduced acute grade 2+ gastrointestinal toxicity. However, 26.5% of patients receiving the spacer experienced a minimal clinically important decline (MCID) in bowel quality-of-life (QOL). The purpose of this study is to evaluate whether certain characteristics of the rectal spacer, as determined on postimplant imaging, were associated with change in bowel QOL at 3-months. METHODS AND MATERIALS: This is a secondary analysis of the 136 patients who received the HA spacer on the randomized trial. Postimplant spacer characteristics (ie, prostate-rectum spacing at superior/midgland/inferior/apex planes, symmetry, prostate volume, spacer volume) were systematically analyzed from structure sets using custom software code. Characteristics demonstrating significant associations with rectal V30 on multivariate linear regression were identified. Linear regression models were used to analyze the associations of such characteristics with change (baseline to 3 months) in both bowel and urinary QOL. RESULTS: Apical spacing (mean 9.4 (standard deviation 4.0)) was significantly smaller than spacing measurements at more superior planes. 95.6% of patients had a symmetrical implant. Apical spacing (P = 10 mm versus 36.6% for
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston, Massachusetts. Electronic address: martin_king@dfci.harvard.edu.
- Palette Life Sciences, Santa Barbara, California.
- Chell Scientific Consulting, Oakland, California.
- Comprehensive Blood and Cancer Center, Bakersfield, California.
- ProPharma, New York, New York.
- Department of Radiation Oncology, University of California Los Angeles, Los Angeles, California.
Zitieren
APA
King, M. T., Svatos, M., Chell, E. W., Pigrish, V., Miller, K., Low, D. A., & Orio, P. F. (2024). Evaluating the Quality-of-Life Effect of Apical Spacing with Hyaluronic Acid Prior to Hypofractionated Prostate Radiation Therapy: A Secondary Analysis. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2023.11.010
Vancouver
King MT, Svatos M, Chell EW, Pigrish V, Miller K, Low DA, et al. Evaluating the Quality-of-Life Effect of Apical Spacing with Hyaluronic Acid Prior to Hypofractionated Prostate Radiation Therapy: A Secondary Analysis. Practical Radiation Oncology. 2024. doi:10.1016/j.prro.2023.11.010
BibTeX
@article{King2024,
author = {King, Martin T and Svatos, Michelle and Chell, Erik W and Pigrish, Vadim and Miller, Katie and Low, Daniel A and Orio, Peter F},
title = {Evaluating the Quality-of-Life Effect of Apical Spacing with Hyaluronic Acid Prior to Hypofractionated Prostate Radiation Therapy: A Secondary Analysis},
journal = {Practical Radiation Oncology},
year = {2024},
doi = {10.1016/j.prro.2023.11.010}
}
EUVIMED